Clinical trials

  • CANNABIDIOL for Prostate cancer | Castration-resistant prostate cancer
  • TEPLIZUMAB for Type 1 diabetes | Stage 3 Type 1 diabetes
  • ISOFLURANE for Delirium
  • DURVALUMAB for Hepatocellular carcinoma | Intermediate stage hepatocellular carcinoma (HCC) | Hepatocellular carcinoma non-resectable
  • RILVEGOSTOMIG for Non-small cell lung cancer (non-squamous, metastatic; PD-L1 expressing)
  • FREXALIMAB for Multiple sclerosis
  • Atezolizumab for Triple negative breast cancer (inoperable locally advanced or metastatic)
  • BRIGATINIB for Non-small cell lung cancer | ALK-positive non-small cell lung cancer
  • NIVOLUMAB for Stage III melanoma
  • DABRAFENIB for Cancer|Rare cancer
  • BISPECIFIC PROTEIN WITH A HIGH-AFFINITY T-CELL RECEPTOR DOMAIN FUSED TO AN ANTIBODY SINGLE-CHAIN VARIABLE FRAGMENT AGAINST CD3 for Chronic HIV infection|HIV infection
  • LENTIVIRAL VECTOR DERIVED FROM THE EQUINE INFECTIOUS ANAEMIA VIRUS CONTAINING THE HUMAN MYO7A GENE for Usher syndrome type 1B